A subsequent study further demonstrated elevated levels of annexins A1 and A2 in skeletal muscles affected by dysferlinopathy and other muscular disorders, indicating that annexin levels are not exclusive markers for dysferlinopathies. This evidence concerns the gene ANXA1 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.